e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Treatment and control of respiratory disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Discordant symptom severity in COPD: The PHAROAH study
Mark Orme (Loughborough, United Kingdom), Mark Orme, Dale Esliger, Mike Morgan, Sally Singh, Michael Steiner, Andrew Kingsnorth, Lauren Sherar
Source:
International Congress 2015 – Treatment and control of respiratory disease
Session:
Treatment and control of respiratory disease
Session type:
Thematic Poster Session
Number:
4054
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mark Orme (Loughborough, United Kingdom), Mark Orme, Dale Esliger, Mike Morgan, Sally Singh, Michael Steiner, Andrew Kingsnorth, Lauren Sherar. Discordant symptom severity in COPD: The PHAROAH study. Eur Respir J 2015; 46: Suppl. 59, 4054
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Predictive role of mMRC scale on quality of life in COPD patients
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013
Association of illness perceptions with psycho-demographic factors and physical activity in COPD patients
Source: International Congress 2016 – Measuring physical activity in chronic respiratory disease
Year: 2016
Impact of lung function impairment and exacerbation history on COPD patient-reported utility
Source: International Congress 2014 – COPD markers
Year: 2014
Quality of life (QL) depending on psychological disorders (PD) of patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Comorbidities
Year: 2014
Measurement of COPD’s impact using the COPD assessment test (CAT) and symptom assessment differences between patients and family members
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Association of asthma admissions and health related quality of life (HRQoL), asthma control and severity
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Which are the main determinants of quality-of-life in severe asthma?
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Fatigue is related to decreased health status in COPD
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Psychological status in COPD patients of Kirov region
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Application CAT questionnaire of the treatment of patients with COPD
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013
Validity of COPD assessment test (CAT) in patients with cardiovascular co-morbidities
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Fatigue and decreased health can predict mortality in COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
The relationship between dyspnea and detection of depression in COPD patients (pts)
Source: International Congress 2015 – Different data in COPD
Year: 2015
Quality of life, oxygen desaturation and dyspnea during ADL in non-hypoxemic patients grouped according symptoms by combined COPD assessment
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014
Does health related quality of life predict severe physical inactivity in COPD?
Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity
Year: 2013
BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity?
Source: International Congress 2014 – Clinical presentations
Year: 2014
Effects of sitting time on dyspnea, quality of life, and BODE score in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Factors associated with quality of life measured by EQ-5D in Korean COPD patients
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013
Loneliness and lack of social support severely influences patients’ quality of life. Secondary findings from our focusgroup study in asthma and COPD patients
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept